Study type: Human research · Status: Citation identity verified

Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure.

European journal of pharmacology · 2024

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

Humanin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
MOTS-c: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.